Tackling tuberculosis with garden dirt
02 March, 2017 by Adam FloranceTuberculosis may seem like a disease of yesteryear, but new drug-resistant strains of Mycobacterium tuberculosis are on the rise.
3D-printed sternum successfully implanted
28 February, 2017A collaboration between CSIRO, Anatomics and British doctors has resulted in the world's first implementation of a 3D-printed titanium and polymer sternum into a patient.
Medicinal cannabis access fast-tracked for Australian patients
22 February, 2017 by Lauren DavisThe Turbull government will facilitate faster access by qualified doctors to medicinal cannabis for approved patients.
Alzheimer's drug trial abandoned due to lack of efficacy
16 February, 2017 by Lauren DavisPharmaceutical company MSD has ended its phase 2/3 study evaluating the drug verubecestat in patients with mild to moderate forms of Alzheimer's disease (AD).
Breakthrough in treating diabetic kidney disease
13 February, 2017Researchers have prevented the progression of diabetic kidney disease (DKD) in laboratory studies of type 2 diabetes, signalling an important breakthrough in the field of diabetes research.
Ebola treatment developed from horse antibodies
08 February, 2017Antibodies sourced from horses could be used as part of post-exposure treatment in the next Ebola outbreak, according to an international research team.
Accelerated HIV reduction in animal trial
07 February, 2017Biotron has completed its HIV-1 animal trial of drug candidate BIT225, announcing positive results which caused the company's share prices to rise by almost 15%.
Fibrosis drug inspired by a shark antibody
01 February, 2017Scientists from La Trobe University and biotechnology company AdAlta have created a humanised version of an antibody found in Wobbegong sharks.
Bioprinted kidneys
25 January, 2017 by Adam FloranceA collaborative effort between the Murdoch Childrens Research Institute, the Methuselah Foundation and Organovo has created a new hope for children suffering from kidney disease, with a pioneering use of 3D bioprinting technology.
The needle that makes brain surgery safer
23 January, 2017Researchers have developed a brain biopsy needle with a tiny imaging probe inside, enabling surgeons to 'see' and avoid at-risk blood vessels as they insert the needle into patients' brains.
Lonza to acquire capsule manufacturer Capsugel
21 December, 2016Lonza Group has entered into a definitive agreement to acquire drug capsule manufacturer Capsugel from the latter's parent organisation, KKR.
Add-on asthma treatments now available through the PBS
20 December, 2016The Turnbull government will invest close to $130 million to give Australian asthma sufferers subsidised access to breakthrough medicines through the Pharmaceutical Benefits Scheme (PBS).
The golden touch: light-activated nanoparticles to treat macular degeneration
19 December, 2016For sufferers of age-related macular degeneration (AMD), the only way to prevent severe vision loss is to endure regular injections into the back of the eye.
Biomedical Translation Fund managers announced
13 December, 2016The Turnbull government has selected the three venture capital fund managers who will manage the Biomedical Translation Fund (BTF), intended to help take Australian biomedical discoveries out of the laboratory and to the patient.
White blood cells at the ready for chemo patients
06 December, 2016University of Queensland (UQ) researchers have developed a way to produce and administer white blood cells to cancer patients following chemotherapy.
